Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biology

Journal of Hematology and Oncology

Volumn 3, Issue , 2010, Pages

  Sacco, Antonio ^a   Issa, Ghayas C ^a   Zhang, Yong ^a   Liu, Yang ^a   Maiso, Patricia ^a   Ghobrial, Irene M ^a   Roccaro, Aldo M ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; MICRORNA; MICRORNA 101; MICRORNA 155; MICRORNA 184; MICRORNA 206; MICRORNA 363; MICRORNA 494; MICRORNA 542 3P; MICRORNA 9; UNCLASSIFIED DRUG; HISTONE;

ACETYLATION; CELL PROLIFERATION; CYTOGENETICS; DISEASE COURSE; DNA MODIFICATION; EPIGENETICS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; REVIEW; TUMOR CELL; WALDENSTROEM MACROGLOBULINEMIA; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY;

ACETYLATION; EPIGENOMICS; HISTONES; HUMANS; MICRORNAS; WALDENSTROM MACROGLOBULINEMIA;

EID: 77957366600     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-3-38     Document Type: Review

References (32)

1. Preliminary notes on the development of the wings in normal and mutant strains of drosophila. CH Waddington, Proc Natl Acad Sci USA 1939 25 299 307 10.1073/pnas.25.7.299 16577903
2. Epigenetic cancer therapy makes headway. GS Mack, J Natl Cancer Inst 2006 98 1443 1444 17047192
3. Waldenstrm macroglobulinaemia. IM Ghobrial MA Gertz R Fonseca, Lancet Oncol 2003 4 679 685 10.1016/S1470-2045(03)01246-4 14602248
4. Clinicopathological definition of Waldenström's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenström's Macroglobulinemia. RG Owen SP Treon A Al-Katib R Fonseca PR Greipp ML McMaster E Morra GA Pangalis JF San Miguel AR Branagan MA Dimopoulos, Semin Oncol 2003 30 110 115 10.1053/sonc.2003.50082 12720118
5. Gene expression profiling of Waldenström's macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma. WJ Chng RF Schop T Price-Troska I Ghobrial N Kay DF Jelinek MA Gertz A Dispenzieri M Lacy RA Kyle PR Greipp RC Tschumper R Fonseca PL Bergsagel, Blood 2006 108 2755 2763 10.1182/blood-2006-02-005488 16804116
6. microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia. AM Roccaro A Sacco X Jia AK Azab P Maiso HT Ngo F Azab J Runnels P Quang IM Ghobrial, Blood 2010 116 1506 1514 10.1182/blood-2010-01- 265686 20519629
7. The C-Elegans heterochronic gene Lin-4 encodes small RNAs with antisense complementarity to Lin-14. RC Lee RL Feinbaum V Ambros, Cell 1993 75 843 854 10.1016/0092-8674(93)90529-Y 8252621
8. Systematic discovery of regulatory motifs in human promoters and 3'UTRs by comparison of several mammals. X Xie J Lu EJ Kulbokas TR Golub V Mootha K Lindblad-Toh ES Lander M Kellis, Nature 2005 434 338 345 10.1038/nature03441 15735639
9. MicroRNAs: small RNAs with a big role in gene regulation. L He GJ Hannon, Nat Rev Genet 2004 5 522 531 10.1038/nrg1379 15211354
10. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behaviour. C Roldo E Missiaglia JP Hagan M Falconi P Capelli S Bersani GA Calin S Volinia CG Liu A Scarpa CM Croce, J Clin Oncol 2006 24 4677 4684 10.1200/JCO.2005.05.5194 16966691
11. MicroRNA expression profiles classify human cancers. J Lu g Getz EA Miska E Alvarez-Saavedra J Lamb D Peck A Sweet-Cordero BL Ebert RH Mak AA Ferrando JR Downing T Jacks HR Horvitz TR Golub, Nature 2005 435 834 838 10.1038/nature03702 15944708
12. MicroRNA gene expression deregulation in human breast cancer. MV Iorio M Ferracin CG Liu A Veronese R Spizzo S Sabbioni E Magri M Pedriali M Fabbri M Campiglio S Ménard JP Palazzo A Rosenberg P Musiani S Volinia I Nenci GA Calin P Querzoli M Negrini CM Croce, Cancer Res 2005 65 7065 7070 10.1158/0008-5472.CAN-05-1783 16103053
13. MicroRNA profiling reveals distinctive signatures in B cell chronic lymphocytic leukemias. GA Calin CG Liu C Sevignani M Ferracin N Felli CD Dumitru M Shimizu A Cimmino S Zupo M Dono ML Dell'Aquila H Alder L Rassenti TJ Kipps F Bullrich M Negrini CM Croce, Proc Natl Acad Sci USA 2004 101 11755 11760 10.1073/pnas.0404432101 15284443
14. microRNA expression in the biology, prognosis and therapy of Waldenstrom Macroglobulinemia. AM Roccaro A Sacco C Chen J Runnels X Leleu F Azab AK Azab X Jia HT Ngo MR Melhem N Burwick L Varticovski CD Novina BJ Rollins KC Anderson IM Ghobrial, Blood 2009 113 4391 4402 10.1182/blood-2008-09-178228 19074725
15. miR-155/BIC as an oncogenic microRNA. W Tam JE Dahlberg, Genes Chromosomes Cancer 2006 45 211 212 10.1002/gcc.20282 16252262
16. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. PS Eis W Tam L Sun A Chadburn Z Li MF Gomez E Lund JE Dahlberg, Proc Natl Acad Sci USA 2005 102 3627 3632 10.1073/pnas.0500613102 15738415
17. Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma. D Rai S Karanti I Jung PL Dahia RC Aguiar, Cancer Genet Cytogenet 2008 181 8 15 10.1016/j.cancergencyto.2007.10.008 18262046
18. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Kluvier S Poppema D de Jong T Blokzijl G Harms S Jacobs BJ Kroesen A van den Berg, J Pathol 2005 207 243 249 10.1002/path.1825 16041695
19. The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: interplay of growth factors, their receptors and stromal interactions. CS Mitsiades NS Mitsiades NC Munshi PG Richardson KC Anderson, Eur J Cancer 2006 42 1564 1573 10.1016/j.ejca.2005.12. 025 16765041
20. PAK is regulated by PI3K, PIX, Cdc42 and PP2Calpha and mediates focal adhesion turnover in the hyperosmotic stress-induced P38 pathway. PM Chan L Lim E Manser, J Biol Chem 2008 283 24949 24961 10.1074/jbc.M801728200 18586681
21. Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma. Y Alsayed H Ngo J Runnels X Leleu UK Singha CM Pitsillides JA Spencer T Kimlinger JM Ghobrial X Jia G Lu M Timm A Kumar D Cté I Veilleux KE Hedin GD Roodman TE Witzig AL Kung T Hideshima KC Anderson CP Lin IM Ghobrial, Blood 2007 109 2708 2717 17119115
22. Epigenetic cancer therapy makes headway. GS Mack, J Natl Cancer Inst 2006 98 1443 1444 17047192
23. The mammalian epigenome. BE Bernstein A Meissner ES Lander, Cell 2007 128 669 681 10.1016/j.cell.2007.01.033 17320505
24. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells. PY Liu JY Chan HC Lin SL Wang ST Liu CL Ho LC Chang SM Huang, Mol Cancer Res 2008 6 1204 1214 10.1158/1541-7786.MCR-08-0123 18644983
25. Anticancer activities of histone deacetylase inhibitors. JE Bolden MJ Peart RW Johnstone, Nat Rev Drug Discov 2006 5 769 784 10.1038/nrd2133 16955068
26. A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition. S Ropero MF Fraga E Ballestar R Hamelin H Yamamoto M Boix-Chornet R Caballero M Alaminos F Setien MF Paz M Herranz J Palacios D Arango TF Orntoft LA Aaltonen S Schwartz Jr M Esteller, Nat Genet 2006 38 566 569 10.1038/ng1773 16642021
27. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. M Fabbri R Garzon A Cimmino Z Liu N Zanesi E Callegari S Liu H Alder S Costinean C Fernandez-Cymering S Volinia G Guler CD Morrison KK Chan G Marcucci GA Calin K Huebner CM Croce, Proc Natl Acad Sci 2007 140 15805 15810 10.1073/pnas.0707628104 (Pubitemid 350035380)
28. The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. PA Cloos J Christensen K Agger A Maiolica J Rappsilber T Antal KH Hansen K Helin, Nature 2006 442 307 311 10.1038/nature04837 16732293
29. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene repression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. R Garzon S Liu M Fabbri Z Liu CE Heaphy E Callegari S Schwind J Pang J Yu N Muthusamy V Havelange S Volinia W Blum LJ Rush D Perrotti M Andreeff CD Bloomfield JC Byrd K Chan LC Wu CM Croce G Marcucci, Blood 2009 113 6411 6418 10.1182/blood-2008-07-170589 19211935
30. miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. EJ Noonan RF Place D Pookot S Basak JM Whitson H Hirata C Giardina R Dahiya, Oncogene 2009 28 1714 1724 10.1038/onc.2009.19 19252524
31. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. S Varambally Q Cao RS Maini S Shankar X Wang B Ateeq B Laxman X Cao X Jing K Ramnarayanan JC Brenner J Yu JH Kim B Han P Tan C Kumar-Sinha RJ Lonigro N Palanisamy CA Maher AM Chinnaiyan, Science 2008 322 1695 1699 10.1126/science.1165395 19008416
32. The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. JM Friedman G Liang CC Liu EM Wolff YC Tsai W Ye X Zhou PA Jones, Cancer Res 2009 69 2623 2629 10.1158/0008-5472.CAN-08-3114 19258506